240 related articles for article (PubMed ID: 15280456)
1. Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism.
Pettit SC; Everitt LE; Choudhury S; Dunn BM; Kaplan AH
J Virol; 2004 Aug; 78(16):8477-85. PubMed ID: 15280456
[TBL] [Abstract][Full Text] [Related]
2. Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral protease.
Pettit SC; Clemente JC; Jeung JA; Dunn BM; Kaplan AH
J Virol; 2005 Aug; 79(16):10601-7. PubMed ID: 16051852
[TBL] [Abstract][Full Text] [Related]
3. Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates.
Pettit SC; Lindquist JN; Kaplan AH; Swanstrom R
Retrovirology; 2005 Nov; 2():66. PubMed ID: 16262906
[TBL] [Abstract][Full Text] [Related]
4. The dimer interfaces of protease and extra-protease domains influence the activation of protease and the specificity of GagPol cleavage.
Pettit SC; Gulnik S; Everitt L; Kaplan AH
J Virol; 2003 Jan; 77(1):366-74. PubMed ID: 12477841
[TBL] [Abstract][Full Text] [Related]
5. Intracellular localization of human immunodeficiency virus type 1 Gag and GagPol products and virus particle release: relationship with the Gag-to-GagPol ratio.
Haraguchi H; Sudo S; Noda T; Momose F; Kawaoka Y; Morikawa Y
Microbiol Immunol; 2010 Dec; 54(12):734-46. PubMed ID: 21091985
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain.
Zybarth G; Kräusslich HG; Partin K; Carter C
J Virol; 1994 Jan; 68(1):240-50. PubMed ID: 8254734
[TBL] [Abstract][Full Text] [Related]
7. Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing.
Bardy M; Gay B; Pébernard S; Chazal N; Courcoul M; Vigne R; Decroly E; Boulanger P
J Gen Virol; 2001 Nov; 82(Pt 11):2719-2733. PubMed ID: 11602784
[TBL] [Abstract][Full Text] [Related]
8. In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes.
Lindhofer H; von der Helm K; Nitschko H
Virology; 1995 Dec; 214(2):624-7. PubMed ID: 8553565
[TBL] [Abstract][Full Text] [Related]
9. Regulation of intracellular human immunodeficiency virus type-1 protease activity.
Gatlin J; Arrigo SJ; Schmidt MG
Virology; 1998 Apr; 244(1):87-96. PubMed ID: 9581782
[TBL] [Abstract][Full Text] [Related]
10. Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1.
Chen N; Morag A; Almog N; Blumenzweig I; Dreazin O; Kotler M
J Gen Virol; 2001 Mar; 82(Pt 3):581-590. PubMed ID: 11172099
[TBL] [Abstract][Full Text] [Related]
11. C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.
Yu FH; Huang KJ; Wang CT
J Virol; 2017 May; 91(10):. PubMed ID: 28250114
[TBL] [Abstract][Full Text] [Related]
12. Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing.
Zybarth G; Carter C
J Virol; 1995 Jun; 69(6):3878-84. PubMed ID: 7745738
[TBL] [Abstract][Full Text] [Related]
13. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
[TBL] [Abstract][Full Text] [Related]
14. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
Quillent C; Borman AM; Paulous S; Dauguet C; Clavel F
Virology; 1996 May; 219(1):29-36. PubMed ID: 8623542
[TBL] [Abstract][Full Text] [Related]
15. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
16. Overexpression and incorporation of GagPol precursor does not impede packaging of HIV-1 tRNA(Lys3) but promotes intracellular budding of virus-like particles.
Shehu-Xhilaga M; Lee JY; Campbell S; Marshall JA; Crowe SM; Mak J
J Biomed Sci; 2002; 9(6 Pt 2):697-705. PubMed ID: 12432236
[TBL] [Abstract][Full Text] [Related]
17. Analysis of human immunodeficiency virus type 1 containing HERV-K protease.
Padow M; Lai L; Fisher RJ; Zhou YC; Wu X; Kappes JC; Towler EM
AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1973-80. PubMed ID: 11153080
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
Paulus C; Ludwig C; Wagner R
Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
[TBL] [Abstract][Full Text] [Related]
19. Control of human immunodeficiency virus type-1 protease activity in insect cells expressing Gag-Pol rescues assembly of immature but not mature virus-like particles.
Adamson CS; Nermut M; Jones IM
Virology; 2003 Mar; 308(1):157-65. PubMed ID: 12706099
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus (HIV) type 1 transframe protein can restore activity to a dimerization-deficient HIV protease variant.
Dautin N; Karimova G; Ladant D
J Virol; 2003 Aug; 77(15):8216-26. PubMed ID: 12857890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
